154 results
Page 4 of 8
DEFR14A
tp36p1kqzv0dqfr3s0
7 May 21
Revised proxy
5:20pm
PRE 14A
t6v982ek0kb1 bm1u
26 Apr 21
Preliminary proxy
5:24pm
UPLOAD
ggrp3c
29 Mar 21
Letter from SEC
12:00am
8-K
EX-10.1
tb5q72dp0 ak53b
9 Mar 21
Hoth Therapeutics Announces $15 Million Private Placement
8:30am
8-K
EX-10.2
35dcq
9 Mar 21
Hoth Therapeutics Announces $15 Million Private Placement
8:30am
8-K
EX-10.4
ofl xzbfc
9 Mar 21
Hoth Therapeutics Announces $15 Million Private Placement
8:30am
8-K
EX-10.3
7x1vqt
9 Mar 21
Hoth Therapeutics Announces $15 Million Private Placement
8:30am
8-K
EX-10.5
pjmllv45xmy7tx c3q5
9 Mar 21
Hoth Therapeutics Announces $15 Million Private Placement
8:30am
UPLOAD
c6vhsur181usx8rfsq
12 Jan 21
Letter from SEC
12:00am
8-K
EX-10.2
o7xgrvq6
8 Jan 21
License Covers Novel Molecular Entity Developed by the Walter Reed Army Institute of Research
4:19pm
8-K
EX-10.1
77iv0085e7k3 0amf
8 Jan 21
License Covers Novel Molecular Entity Developed by the Walter Reed Army Institute of Research
4:19pm
8-K
EX-10.3
acq5onnxkv
8 Jan 21
License Covers Novel Molecular Entity Developed by the Walter Reed Army Institute of Research
4:19pm
8-K
EX-10.4
ovzj2fnag e7rbpv1
8 Jan 21
License Covers Novel Molecular Entity Developed by the Walter Reed Army Institute of Research
4:19pm
8-K
EX-10.1
cnuka2a35ed7
21 Sep 20
Hoth Therapeutics Enters into Sponsored Research Agreement for On-the-go COVID-19 Testing Device
4:15pm